Cite
Cancer immunotherapy beyond immune checkpoint inhibitors
MLA
Yanyan Lou, et al. “Cancer Immunotherapy beyond Immune Checkpoint Inhibitors.” Journal of Hematology & Oncology, vol. 11, Jan. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c9265834ddb8500044f4c6c95d291f65&authtype=sso&custid=ns315887.
APA
Yanyan Lou, Keith L. Knutson, Aixa E. Soyano, Bhagirathbhai Dholaria, & Julian A. Marin-Acevedo. (2018). Cancer immunotherapy beyond immune checkpoint inhibitors. Journal of Hematology & Oncology, 11.
Chicago
Yanyan Lou, Keith L. Knutson, Aixa E. Soyano, Bhagirathbhai Dholaria, and Julian A. Marin-Acevedo. 2018. “Cancer Immunotherapy beyond Immune Checkpoint Inhibitors.” Journal of Hematology & Oncology 11 (January). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c9265834ddb8500044f4c6c95d291f65&authtype=sso&custid=ns315887.